Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex
10.1016/j.bmcl.2006.12.032 17196389
Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex. Efthimiadou EK, Katsaros N, Karaliota A, Psomas G, Bioorg Med Chem Lett 2007 17 1238 1242 10.1016/j.bmcl.2006.12.032 17196389
Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria
10.2174/138955706776361493 16613574
Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria. Emami S, Shafiee A, Foroumadi A, Mini Rev Med Chem 2006 6 375 386 10.2174/138955706776361493 16613574
Synthesis and biological testing of non-fluorinated analogues of Levofloxacin
DOI 10.1016/S0960-894X(03)00399-8
Synthesis and biological testing of non-fluorinated analogues of levofloxacin. Jeffrey LJ, Almstead JK, Gallagher CP, Hu XE, Kim NK, Taylor CJ, Twinem TL, Cynthia D, Bioorg Med Chem Lett 2003 13 2373 2375 10.1016/S0960-894X(03)00399-8 12824037 (Pubitemid 36724985)
Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa
10.1016/S0924-8579(99)00119-3 10724029
Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa. Segatore B, Setacci D, Perilli M, Franceschini N, Marchetti F, Amicosante G, Int J Antimicrob Agents 2000 13 223 226 10.1016/S0924-8579(99)00119-3 10724029
Synthesis and antibacterial activity of new 7-piperazinylquinolones containing a functionalized 2-(furan-3-yl)ethyl moiety
DOI 10.1002/ardp.200600169
Synthesis and antibacterial activity of new 7-piperazinylquinolones containing a functionalized 2-(furan-3-yl)ethyl moiety. Foroumadi A, Mohammadhosseini N, Emami S, Letafat B, Faramarzi MA, Samadi N, Shafiee A, Arch Pharm 2007 340 47 52 10.1002/ardp.200600169 (Pubitemid 46154835)
Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety
DOI 10.1016/j.bmcl.2006.03.103, PII S0960894X06004021
Synthesis and antibacterial activity of new N-(phenethyl)piperazine moiety. Foroumadi A, Ghodsi S, Emami S, Najjari S, Samadi N, Faramarzi MA, Beikmohammadi L, Shirazi FH, Shafiee A, Bioorg Med Chem Lett 2006 16 3499 3503 10.1016/j.bmcl.2006.03.103 16644219 (Pubitemid 43777121)
Synthesis and antibacterial activity of new N-[2-(thiophen-3-yl)ethyl] piperazinyl quinolones
DOI 10.1248/cpb.55.894
Synthesis and antibacterial activity of new N-[2-(thiophen-3-yl)ethyl] piperazinyl quinolones. Letafat B, Emami S, Mohammadhoseini N, Faramarzi MA, Samadi N, Shafiee A, Foroumadi A, Chem Pharm Bull 2007 55 894 898 10.1248/cpb.55.894 17541188 (Pubitemid 46890089)
Synthesis and in-vitro antibacterial activity of N-piperazinyl quinolone derivatives with 5-chloro-2-thienyl group
Synthesis and in-vitro antibacterial activity of N-piperazinyl quinolone derivatives with 5-chloro-2-thienyl group. Shafiee A, Haddad Zahmatkesh M, Mohammadhosseini N, Khalafy J, Emami S, Moshafi MH, Sorkhi M, Foroumadi A, Daru 2008 16 189 195
Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring
DOI 10.1016/j.ejmech.2006.12.034, PII S0223523407000323
Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring. Foroumadi A, Emami S, Mansouri S, Javidnia A, Saeid-Adeli N, Shirazi FH, Shafiee A, Eur J Med Chem 2007 42 985 992 10.1016/j.ejmech.2006.12.034 17316916 (Pubitemid 46907340)
Synthesis and antibacterial activities of optically active ofloxacin and its fluoromethyl derivative
10.1248/cpb.35.1896 3664798
Synthesis and antibacterial activities of optically active ofloxacin and its fluoromethyl derivative. Atarashi S, Yokohama S, Yamazaki KI, Sakano KI, Imamura M, Chem Pharm Bull 1987 35 1896 1902 10.1248/cpb.35.1896 3664798